Board of Directors

Norbert G. Riedel, Ph.D.

Executive Chairman of the Board

Patrick Enright

Lead Independent Director
Founder and Managing Director, Longitude Capital

Henry O. Gosebruch 

Executive Vice President and Chief Strategy Officer, AbbVie Inc.

Terry P. Gould

Partner and Head of Venture / Growth Equity Investments, Adams Street Partners

Robert J. Hombach

Retired CFO, Baxter International Inc. and Baxalta Inc.

Andy Kidd, M.D.

President & CEO, Aptinyx

Adam M. Koppel, M.D., Ph.D.

Managing Director, Bain Capital Life Sciences

Joan W. Miller, M.D.

David Glendenning Cogan Professor of Ophthalmology and Chair of the Department of Ophthalmology, Harvard Medical School
Chief of Ophthalmology, Massachusetts Eye and Ear and Massachusetts General Hospital

Gilmore O’Neill, M.B., M.M.Sc.

Former Executive Vice President of Research and Development and Chief Medical Officer, Sarepta Therapeutics
Former Senior Vice President, Late Stage Clinical Development, Biogen

Rachel Sherman, M.D., M.P.H.

Retired Principal Deputy Commissioner of FDA